+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Live Attenuated Vaccine"

Rabies Vaccines for Animals Market - Global Forecast 2025-2030 - Product Thumbnail Image

Rabies Vaccines for Animals Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Mumps Virus Vaccine Live Market - Global Forecast 2025-2030 - Product Thumbnail Image

Mumps Virus Vaccine Live Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 184 Pages
  • Global
From
Avian Influenza Vaccines Market - Global Forecast 2025-2030 - Product Thumbnail Image

Avian Influenza Vaccines Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
From
From
Dengue Vaccine Market - Global Forecast 2025-2030 - Product Thumbnail Image

Dengue Vaccine Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
Rotavirus Vaccine Market - Global Forecast 2025-2030 - Product Thumbnail Image

Rotavirus Vaccine Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 193 Pages
  • Global
From
FeLV Vaccine Market - Global Forecast 2025-2030 - Product Thumbnail Image

FeLV Vaccine Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
Multivalent Influenza Vaccines Market - Global Forecast to 2030 - Product Thumbnail Image

Multivalent Influenza Vaccines Market - Global Forecast to 2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Animal Parvovirus Vaccine Market - Global Forecast 2025-2030 - Product Thumbnail Image

Animal Parvovirus Vaccine Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
From
From
From
Recombinant Vaccines - Global Strategic Business Report - Product Thumbnail Image

Recombinant Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 383 Pages
  • Global
From
Inactivated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 468 Pages
  • Global
From
Multivalent Vaccines - Global Strategic Business Report - Product Thumbnail Image

Multivalent Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 278 Pages
  • Global
From
Nasal Vaccines - Global Strategic Business Report - Product Thumbnail Image

Nasal Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 220 Pages
  • Global
From
Typhoid Fever Vaccines - Global Strategic Business Report - Product Thumbnail Image

Typhoid Fever Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 372 Pages
  • Global
From
Vaccine Technologies - Global Strategic Business Report - Product Thumbnail Image

Vaccine Technologies - Global Strategic Business Report

  • Report
  • October 2025
  • 573 Pages
  • Global
From
Hepatitis A Vaccines - Global Strategic Business Report - Product Thumbnail Image

Hepatitis A Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 282 Pages
  • Global
From
Loading Indicator

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus. Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines. Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more